Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 3
1969 3
1971 3
1972 1
1973 4
1974 1
1975 2
1977 6
1978 4
1979 5
1980 5
1981 9
1982 2
1983 11
1984 11
1985 14
1986 8
1987 8
1988 13
1989 18
1990 20
1991 20
1992 22
1993 39
1994 32
1995 39
1996 33
1997 17
1998 29
1999 35
2000 33
2001 30
2002 26
2003 38
2004 35
2005 31
2006 29
2007 35
2008 44
2009 41
2010 74
2011 62
2012 53
2013 58
2014 67
2015 68
2016 53
2017 63
2018 65
2019 54
2020 64
2021 82
2022 82
2023 80
2024 24

Text availability

Article attribute

Article type

Publication date

Search Results

1,565 results

Results by year

Filters applied: . Clear all
Page 1
Combination therapy for visceral leishmaniasis.
van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M. van Griensven J, et al. Lancet Infect Dis. 2010 Mar;10(3):184-94. doi: 10.1016/S1473-3099(10)70011-6. Lancet Infect Dis. 2010. PMID: 20185097 Review.
Intramacrophage lipid accumulation compromises T cell responses and is associated with impaired drug therapy against visceral leishmaniasis.
Araújo M, Moreira D, Mesquita I, Ferreira C, Mendes-Frias A, Barros-Carvalho S, Dinis-Oliveira RJ, Duarte-Oliveira C, Cunha C, Carvalho A, Saha B, Cordeiro-da-Silva A, Estaquier J, Silvestre R. Araújo M, et al. Immunology. 2023 Dec;170(4):510-526. doi: 10.1111/imm.13686. Epub 2023 Aug 27. Immunology. 2023. PMID: 37635289
Walking a tightrope: drug discovery in visceral leishmaniasis.
Balaña-Fouce R, Pérez Pertejo MY, Domínguez-Asenjo B, Gutiérrez-Corbo C, Reguera RM. Balaña-Fouce R, et al. Drug Discov Today. 2019 May;24(5):1209-1216. doi: 10.1016/j.drudis.2019.03.007. Epub 2019 Mar 12. Drug Discov Today. 2019. PMID: 30876846 Review.
Managing visceral leishmaniasis.
Bansal N, Jain A. Bansal N, et al. BMJ. 2023 Oct 16;383:2213. doi: 10.1136/bmj.p2213. BMJ. 2023. PMID: 37844956 No abstract available.
Drug combinations for visceral leishmaniasis.
Olliaro PL. Olliaro PL. Curr Opin Infect Dis. 2010 Dec;23(6):595-602. doi: 10.1097/QCO.0b013e32833fca9d. Curr Opin Infect Dis. 2010. PMID: 20871400 Review.
1,565 results